Cotempla XR-ODT - Another Long-Acting Methylphenidate for ADHD

Date: November 6, 2017
Issue #: 
1533Summary: 
The FDA has approved an extended-release orally
disintegrating tablet formulation of methylphenidate
(Cotempla XR-ODT– Neos Therapeutics) for once-daily
treatment of attention-defi cit/hyperactivity
disorder (ADHD) in children 6-17 years old.Cotempla XR-ODT is the first extended-release orally
disintegrating tablet formulation of methylphenidate
to become available in the US.

Source: The Medical Letter - October 30, 2017 Category: Drugs & Pharmacology Authors: admin Tags: ADHD Aptensio Concerta Contempla daytrana Dexmethylphenidate Focalin methyphenidate QuiliChew Quilivant Ritalin Source Type: research